Home » Newsletters » BioWorld Science

BioWorld Science

Jan. 10, 2022

View Archived Issues

Down syndrome linked to senescence-like state

Identification of novel drug candidates targeting dengue virus capsid protein

Indirect radiolabeling of pGlu for intratumoral delivery of alpha- and beta-particle emitters

Novel roe-inspired MSC microcapsules for the treatment of IBD

Researchers publish data on DDR kinase inhibitor XBLJ-13 for pulmonary fibrosis

Tucatinib plus anti-HER2 antibody NSCs prolong survival of mice with brain-metastatic breast cancer

Dana-Farber Cancer Institute patents UCP1 activators

The Vanderbilt University divulges new muscarinic M5 receptor antagonists

Gossamer Bio presents DGKA and/or DGKZ inhibitors

Incyte synthesizes new JAK2 V617F inhibitors

Volastra Therapeutics identifies ENPP1 inhibitors

NHMRC grant supports exploration of Pharmaxis serine protease inhibitor for tissue repair

Bayer and Mammoth Biosciences enter collaboration and option agreement on Mammoth's CRISPR systems

MAP3K7 modulation to treat MDS-associated anemia

Pfizer and Beam Therapeutics collaborate to advance in vivo base editing programs

EsoCap and Upadia sign licensing agreement to develop therapeutics to treat Barrett's esophagus

Cullinan collaborates with Mount Sinai to develop HPK1 protein degraders for cancer

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 30, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...
5-HT2R allosteric ligands attenuate cocaine use and seeking behavior
BioWorld Science
Serotonergic G-protein-coupled receptors (GPCRs), including the 5-HT2A receptor (5-HT2AR) and 5-HT2CR, are key regulators of cortical signaling pathways and...